-
Louvre closes for the day due to strike
-
Prince Harry lawyer claims 'systematic' UK newspaper group wrongdoing as trial opens
-
Centurion Djokovic romps to Melbourne win as Swiatek, Gauff move on
-
Brignone unsure about Olympics participation ahead of World Cup comeback
-
Roger Allers, co-director of "The Lion King", dead at 76
-
Senegal awaits return of 'heroic' AFCON champions
-
Trump to charge $1bn for permanent 'peace board' membership: reports
-
Trump says world 'not secure' until US has Greenland
-
Gold hits peak, stocks sink on new Trump tariff threat
-
Champions League crunch time as pressure piles on Europe's elite
-
Harry arrives at London court for latest battle against UK newspaper
-
Swiatek survives scare to make Australian Open second round
-
Over 400 Indonesians 'released' by Cambodian scam networks: ambassador
-
Japan PM calls snap election on Feb 8 to seek stronger mandate
-
Europe readying steps against Trump tariff 'blackmail' on Greenland: Berlin
-
What is the EU's anti-coercion 'bazooka' it could use against US?
-
Infantino condemns Senegal for 'unacceptable scenes' in AFCON final
-
Gold, silver hit peaks and stocks sink on new US-EU trade fears
-
Trailblazer Eala exits Australian Open after 'overwhelming' scenes
-
Warhorse Wawrinka stays alive at farewell Australian Open
-
Bangladesh face deadline over refusal to play World Cup matches in India
-
High-speed train collision in Spain kills 39, injures dozens
-
Gold, silver hit peaks and stocks struggle on new US-EU trade fears
-
Auger-Aliassime retires in Melbourne heat with cramp
-
Melbourne home hope De Minaur 'not just making up the numbers'
-
Risking death, Indians mess with the bull at annual festival
-
Ghana's mentally ill trapped between prayer and care
-
UK, France mull social media bans for youth as debate rages
-
Japan PM to call snap election seeking stronger mandate
-
Switzerland's Ruegg sprints to second Tour Down Under title
-
China's Buddha artisans carve out a living from dying trade
-
Stroking egos key for Arbeloa as Real Madrid host Monaco
-
'I never felt like a world-class coach', says Jurgen Klopp
-
Ruthless Anisimova races into Australian Open round two
-
Australia rest Cummins, Hazlewood, Maxwell for Pakistan T20 series
-
South Korea, Italy agree to deepen AI, defence cooperation
-
Vietnam begins Communist Party congress to pick leaders
-
China's 2025 economic growth among slowest in decades
-
Gauff, Medvedev through in Australia as Djokovic begins record Slam quest
-
Who said what at 2025 Africa Cup of Nations
-
Grizzlies win in London as heckler interrupts US anthem
-
Three-time finalist Medvedev grinds into Australian Open round two
-
Auger-Aliassime retires from Melbourne first round with cramp
-
Rams fend off Bears comeback as Patriots advance in NFL playoffs
-
Thousands march in US to back Iranian anti-government protesters
-
Gotterup charges to Sony Open victory in Hawaii
-
Gold, silver hit records and stocks fall as Trump fans trade fears
-
Auger-Aliassime retires injured from Melbourne first round
-
Gauff through, Auger-Aliassime retires as Djokovic begins record quest
-
China says economy grew 5% last year, among slowest in decades
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
L.Wyss--VB